To evaluate the impact of VitD treatment on the susceptibility of CD4+ T cells to HIV-1 infection, levels of p24 were quantified in the supernatants from VitD- or EtOH-treated cells after 72 h post-infection using an ELISA assay. This evidence concerns the gene CD4 and HIV-1 infection.